
There is little data about the combined effects of COPD and zzso We compared zzso zzso quality of life zzso zzso and zzso medication use among patients who are overweight and obese to those of normal weight with zzso 

We performed secondary data analysis on 364 Veterans with zzso We zzso subjects by body mass index zzso We assessed zzso using the Medical Research Council zzso zzso scale and zzso using the zzso George's Respiratory zzso We identified treatment for an zzso and zzso medication use in the past zzso We used multiple zzso and linear zzso models as appropriate, with adjustment for age, COPD severity, smoking status, and zzso 

The majority of our population was male zzso zzso zzso zzso and either overweight zzso zzso zzso zzso or obese zzso zzso zzso zzso zzso and overweight subjects had better lung function zzso mean zzso zzso zzso predicted, zzso mean zzso zzso zzso zzso than normal weight subjects zzso zzso zzso zzso zzso yet obese subjects reported increased zzso zzso OR of zzso score zzso zzso zzso zzso zzso zzso zzso poorer zzso and were prescribed more zzso medications than normal weight zzso There was no difference in any outcome between overweight and normal weight zzso 

Despite having less severe lung disease, obese patients reported increased zzso and poorer zzso than normal weight zzso The greater number of zzso medications prescribed for obese patients may represent zzso zzso patients with COPD likely need alternative strategies for symptom control in addition to those currently zzso 

